You have 9 free searches left this month | for more free features.

glucose-dependent insulinotropic polypeptide (GIP)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Semaglutide 1.34 MG/ML [Ozempic]
  • +3 more
  • Hellerup, Capital Region, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022

Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)

Recruiting
  • Blood Flow
  • GIPR antagonist / study tool
  • +2 more
  • Copenhagen, Denmark
    Rigshospitalet
Nov 2, 2022

Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)

Recruiting
  • Acromegaly Due to Pituitary Adenoma
  • GIP-A
  • Placebo
  • Copenhagen, Denmark
    Department of Biomedical Sciences
Nov 1, 2022

Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

Recruiting
  • Type1diabetes
  • +2 more
  • Infusion of GIP[1-42], GIP[1-30] or placebo
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023

Postural Tachycardia Syndrome (POTS) Trial in Nashville (Measurement of Splanchnic venous capacitance(SVC))

Not yet recruiting
  • Postural Tachycardia Syndrome (POTS)
  • Measurement of Splanchnic venous capacitance(SVC)
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Dec 8, 2022

Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

Completed
  • Bariatric Surgery
  • Placebo
  • +3 more
  • Hvidovre, Denmark
  • +1 more
Jan 31, 2022

Healthy Trial in Hvidovre (Glucagon-Like Peptide-2 (GLP-2), Glucose-dependent insulinotropic polypeptide (GIP), GLP-2+GIP)

Completed
  • Healthy
  • Glucagon-Like Peptide-2 (GLP-2)
  • +3 more
  • Hvidovre, Denmark
    Hvidovre University Hospital
Jan 14, 2021

Type2 Diabetes Trial in Hellerup (Placebo, GIP receptor antagonization)

Active, not recruiting
  • Type2 Diabetes
  • Placebo
  • GIP receptor antagonization
  • Hellerup, Capital Region, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Sep 16, 2021

Type2 Diabetes Trial in Copenhagen (Placebo, GIP receptor antagonist, DPP-4 inhibitor)

Completed
  • Type2 Diabetes
  • Placebo
  • +3 more
  • Copenhagen, Hellerup, Denmark
    Center for Clinical Metabolic Research
Mar 15, 2021

Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)

Not yet recruiting
  • Pancreatectomy; Hyperglycemia
  • Intravenous infusion
  • Hellerup, Denmark
    Clinical Metabolic Physiology
Dec 14, 2021

Diabetes, Type 1 Trial in Hellerup (glucose-dependent insulinotropic peptide, Glucose-Dependent Insulin-Releasing Hormone[3-30],

Completed
  • Diabetes Mellitus, Type 1
  • glucose-dependent insulinotropic peptide
  • +2 more
  • Hellerup, Denmark
    Steno Diabetes Center Copenhagen, Clinical Metabolic Physiology
May 5, 2021

Wolfram Syndrome Trial (Tirzepatide)

Not yet recruiting
  • Wolfram Syndrome
  • (no location specified)
Dec 12, 2022

Diabetes, Type 1, Hypoglycemia Trial in Hellerup (GIP)

Completed
  • Diabetes Mellitus, Type 1
  • Hypoglycemia
  • Hellerup, Denmark
    Steno Diabetes Center CopenhagenSteno Diabetes Center Copenhagen
Jan 23, 2020

Obesity, Diabetes, Type 2, Metabolic Syndrome Trial (Cola beverage with aspartame and acesulfame K, Cola beverage with sucrose

Completed
  • Obesity
  • +2 more
  • Cola beverage with aspartame and acesulfame K
  • Cola beverage with sucrose and stevia
  • (no location specified)
Dec 8, 2022

Obesity, Weight Loss Trial in Birmingham (Empagliflozin Arm, Control Arm, Exercise capacity VO2 maximum determination)

Not yet recruiting
  • Obesity
  • Weight Loss
  • Empagliflozin Arm
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
May 22, 2023

Type 2 Diabetes Trial in Hellerup (Sevelamer, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • Hellerup, Denmark
    Steno Diabetes Center Copenhagen, Gentofte Hospital
Oct 12, 2021

Overweight or Obesity Trial in Chicago (Moona Device)

Not yet recruiting
  • Overweight or Obesity
  • Moona Device
  • Chicago, Illinois
    University of Chicago
Apr 27, 2023

PCOS Trial in Montréal (Ketone, Water)

Not yet recruiting
  • PCOS
  • Ketone
  • Water
  • MontrĂ©al, Quebec, Canada
    Cardiovascular Health and Autonomic Research Laboratory
Dec 1, 2023

Healthy Trial (Amino acid bolus infusion)

Not yet recruiting
  • Healthy
  • Amino acid bolus infusion
  • (no location specified)
Jul 12, 2023

Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)

Completed
  • Type 2 Diabetes
  • Obesity
  • Roux-en-Y
  • +4 more
  • Turku, Finland
    Turku univercity hospital, PET center
Oct 12, 2021

Postprandial Lipemia, Postprandial Glycemia, Gastric Emptying Trial in Kajang (HGI+palm olein, LGI+palm olein, HGI+soy bean oil)

Recruiting
  • Postprandial Lipemia
  • +2 more
  • HGI+palm olein
  • +3 more
  • Kajang, Selangor, Malaysia
    Malaysian Palm Oil Board
Jul 28, 2023

Idiopathic Ketotic Hypoglycemia Trial in Hellerup (Oral glucose tolerance test, Mixed meal test)

Active, not recruiting
  • Idiopathic Ketotic Hypoglycemia
  • Oral glucose tolerance test
  • Mixed meal test
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research, Department of Medicine,
Mar 25, 2022

Spinal Cord Injuries Trial in Hvidovre (Meal test, GIP, GLP-2)

Recruiting
  • Spinal Cord Injuries
  • Meal test
  • +4 more
  • Hvidovre, Denmark
    Hvidovre University Hospital
Dec 18, 2021

Type 2 Diabetes Trial in Odense (Low carbohydrate)

Recruiting
  • Type 2 Diabetes
  • Low carbohydrate
  • Odense, Denmark
    Odense University Hospital
Aug 10, 2022

Muscle Wasting in Critically Ill Trial in Basel (Enteral nutrition with Fresubin Intensive)

Recruiting
  • Muscle Wasting in Critically Ill
  • Enteral nutrition with Fresubin Intensive
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel, operative ICU
Jun 15, 2022